參考文獻(xiàn)/References:
[1] COOKSON BT,BRENNAN MA.Pro-inflammatory programmed cell death[J].Trends Microbiol,2001,9(3):113-114.
[2] MAN SM,KARKI R,KANNEGANTI TD.Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases[J].Immunol Rev,2017,277(1):61-75.
[3] JORGENSEN I,MIAO EA.Pyroptotic cell death defends against intracellular pathogens[J].Immunol Rev,2015,265(1):130-142.
[4] BERGSBAKEN T,FINK SL,COOKSON BT.Pyroptosis:host cell death and inflammation[J].Nat Rev Microbiol,2009,7(2):99-109.
[5] SHALINI S,DORSTYN L,DAWAR S,et al.Old,new and emerging functions of caspases[J].Cell Death Differ,2015,22(4):526-539.
[6] HU Z,CHAI J.Structural mechanisms in NLR inflammasome assembly and signaling[J].Curr Top Microbiol Immunol,2016,397:23-42.
[7] LU A,WU H.Structural mechanisms of inflammasome assembly[J].FEBS,2015,282(3):435-444.
[8] MAN SM,KANNEGANTI TD.Regulation of inflammasome activation[J].Immunol Rev,2015,265(1):6-21.
[9] RATHINAM VA,FITZGERALD KA.Inflammasome complexes:emerging mechanisms and effector functions[J].Cell,2016,165(4):792-800.
[10] SUN Q,SCOTT MJ.Caspase-1 as a multifunctional inflammatory mediator:noncytokine maturation roles[J].J Leukoc Biol,2016,100(5):961-967.
[11] SHI JJ,ZHAO YE,WANG K,et al.Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J].Nature,2015,526(7575):660-665.
[12] KAYAGAKI N,STOWE IB,LEE BL,et al.Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling[J].Nature,2015,526(7575):666-671.
[13] JORGENSEN I.RAYAMAJHI M,MIAO EA.Programmed cell death as a defence against infection[J].Nat Rev Immunol,2017,17(3):151-164.
[14] YANG DH,HE Y,MUNOZ-PLANILLO R,et al.Caspase-11 requires the pannexin-1 Channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock[J].Immunity,2015,43(5):923-932.
[15] 盧國(guó),鄭東森,李瀚文,等.NLRP3和TLR4調(diào)控的細(xì)胞焦亡在痛風(fēng)性關(guān)節(jié)炎中的作用[J].藥學(xué)研究,2017,36(5):292-294.
[16] JESUS AA,GOLDBACH-MANSKY R.IL-1 Blockade in autoinflammatory syndromes[J].Annu Rev Med,2014,65:223-244.
中醫(yī)正骨2018年11月第30卷第11期 J Trad Chin Orthop Trauma,2018,Vol.30,No.11(總847)
(總848)中醫(yī)正骨2018年11月第30卷第11期 J Trad Chin Orthop Trauma,2018,Vol.30,No.11
[17] SHI L,XU L,YANG YH,et al.Suppressive effect of modified Simiaowan on experimental gouty arthritis:An in vivo and in vitro study[J].J Ethnopharmacol,2013,150(3):1038-1044.
[18] MARTINON F,PETRILLI V,MAYOR A,et al.Gout-associated uric acid crystals activate the NALP3 inflammasome[J].Nature,2006,440(781):237-241.
[19] 陳昉,姚紅,童娟,等.白子菜提取物對(duì)急性痛風(fēng)性關(guān)節(jié)炎大鼠模型的抗炎免疫作用[J].廣州中醫(yī)藥大學(xué)學(xué)報(bào),2015,32(2):275-281.
[20] WEI H,HUA C,XIE JB,et al.Doliroside a attenuates monosodium urate crystals-induced inflammation by targeting NLRP3 inflammasome[J].Eur J Pharmacol,2014,740:321-328.
[21] 付長(zhǎng)龍,梅陽(yáng)陽(yáng),林潔,等.川芎嗪干預(yù)類風(fēng)濕關(guān)節(jié)炎的機(jī)制探討[J].風(fēng)濕病與關(guān)節(jié)炎,2016,5(9):45-47.
[22] 齊晅,田玉,孫超,等.NF-κB信號(hào)通路的阻斷對(duì)類風(fēng)濕關(guān)節(jié)炎滑膜細(xì)胞凋亡與炎癥的影響[J].中國(guó)老年學(xué)雜志,2015,35(24):7022-7024.
[23] VANDE WALLE L,VAN OPDENBOSCH N,JACQUES PA,et al.Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis[J].Nature,2014,512(7512):69-73.
[24] 謝強(qiáng).miR-223抑制佐劑性關(guān)節(jié)炎大鼠巨噬細(xì)胞NLRP3炎癥小體介導(dǎo)炎癥因子分泌的分子機(jī)制研究[D].合肥:安徽醫(yī)科大學(xué),2016.
[25] 吳小山.酸敏感離子通道1a在佐劑性關(guān)節(jié)炎大鼠關(guān)節(jié)軟骨細(xì)胞焦亡中的作用及其機(jī)制研究[D].合肥:安徽醫(yī)科大學(xué),2017.
[26] CHOULAKI C,PAPADAKI G,REPA AA,et al.Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis[J].Arthritis Res Ther,2015,17(1):257.
[27] 林平冬,翁霞萍,劉發(fā)元,等.牛膝有效成分防治骨關(guān)節(jié)炎的作用機(jī)制探討[J].風(fēng)濕病與關(guān)節(jié)炎,2015,4(2):56-59.
[28] 袁芳,何曉瑾,邱亦江,等.骨關(guān)節(jié)炎的軟骨細(xì)胞凋亡機(jī)制[J].實(shí)用醫(yī)學(xué)雜志,2015,31(4):666-668.
[29] BOILEAU C,MARTEL-PELLETIER J,MOLDOVAN F,et al.The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide[J].Arthritis Rheum,2002,46(10):2637-2647.
[30] KOLLY L,KARABABA M,JOOSTEN LA,et al.lnrlammatory role of ASC:inantigen-induced arthritis is independent of aspase-1,NALP-3,and IPAF[J]. J Immunol,2009,183(6):4003-4012.
[31] 李曉辰.基于NLRP3/Caspase-1炎癥小體對(duì)“易層”貼敷療法外治膝骨關(guān)節(jié)炎中滑膜炎癥的機(jī)制研究[D].南京:南京中醫(yī)藥大學(xué),2018.
[32] ZHANG Y,ZHENG Y,Li H.NLRP3 inflammasome plays an important role in the pathogenesis of collagen-induced arthritis[J].Mediators Inflamm,2016,26(5):62-70.
[33] DENOBLE AE,UFFMAN KM,TABLER TV,et al.Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation.[J].Proc Natl Acad Sci U S A,2011,108(5):2088-2093.
[34] 潘彩彬,劉獻(xiàn)祥.強(qiáng)直性脊柱炎病因及其動(dòng)物模型研究進(jìn)展[J].風(fēng)濕病與關(guān)節(jié)炎,2014,3(7):74-76.
[35] 劉宏瀟,馮興華,李麗,等.強(qiáng)直性脊柱炎成纖維細(xì)胞增殖細(xì)胞周期及凋亡的初步研究[J].中華風(fēng)濕病學(xué)雜志,2005,9(12):758-760.
[36] 徐愿,陶慶文,孔維萍,等.強(qiáng)直性脊柱炎骨化臨床研究進(jìn)展[J].中國(guó)骨質(zhì)疏松雜志,2015,21(12):1504-1507.
[37] KIM SKYJ,CHO YJ,CHOE YJ,et al.NLRP3 inflammasomes and NLRP3 inflammasome-derived proinflammatory cytokines in peripheral blood mononuclear cells of patients with ankylosing spondylitis[J].Clin Chim Acta,2018,486:269-274.
[38] SON CN,BANG SY,KIM JH,et al.Caspase-1 level in synovial fluid is high in patients with spondyloarthropathy but not in patients with gout[J].Korean MedSci,2013,28(9):1289-1292.
相似文獻(xiàn)/References:
[1]孟維娜,明立功,王新德,等.關(guān)節(jié)鏡下清理聯(lián)合腓骨近1/3段截骨治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(11):40.
[2]明立功,孟維娜,王新德,等.腓骨近端截骨治療內(nèi)側(cè)間室膝骨關(guān)節(jié)炎的近期療效觀察[J].中醫(yī)正骨,2015,27(10):25.
[3]張杰,王人彥,張玉柱.膝骨關(guān)節(jié)炎的治療進(jìn)展[J].中醫(yī)正骨,2015,27(10):68.
[4]梁朝,蔡靜怡,閆立,等.針刀療法改善膝骨關(guān)節(jié)炎早期疼痛癥狀的療效評(píng)價(jià)[J].中醫(yī)正骨,2015,27(09):9.
LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):9.
[5]王建武,黨建軍,李強(qiáng),等.四聯(lián)療法治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(08):44.
[6]劉紅娟,郭會(huì)利,郭樹(shù)農(nóng).云克聯(lián)合中藥治療膝骨關(guān)節(jié)炎的護(hù)理[J].中醫(yī)正骨,2015,27(08):75.
[7]陳衛(wèi)衡.探索建立系統(tǒng)的膝骨關(guān)節(jié)炎中醫(yī)臨床科研范式
和理論體系[J].中醫(yī)正骨,2015,27(07):1.
[8]鄭春松,葉蕻芝,李西海,等.透骨消痛膠囊中補(bǔ)腎柔肝藥和活血祛風(fēng)藥治療
骨關(guān)節(jié)炎作用方式的計(jì)算機(jī)模擬比較[J].中醫(yī)正骨,2015,27(07):6.
ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(補(bǔ)腎柔肝)drugs versus Huoxue Qufeng(活血祛風(fēng))drugs contained in Tougu Xiaotong Jiaonang(透骨消痛膠囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):6.
[9]帥波,沈霖,楊艷萍,等.加味青娥丸治療膝骨關(guān)節(jié)炎的作用機(jī)制研究[J].中醫(yī)正骨,2015,27(07):15.
SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):15.
[10]梅其杰,袁長(zhǎng)深,段戡,等.壯藥骨痹方燙熨聯(lián)合運(yùn)動(dòng)療法治療膝骨關(guān)節(jié)炎的臨床研究[J].中醫(yī)正骨,2015,27(07):27.
MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):27.